Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001213900-22-005787

CEO and CFO bought 5,000 shares at $19.59 ($97,950)

From the SEC's structured data for this filing

Trades in this filing

Patel Snehal · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-02-04 Purchase : show line 1 in the form +5,000 $19.59 $97,950 1,199,429 D
Open-market purchases · 5,000 sh · avg $19.59 · $97,950
Loading xslF345X03/ownership.xml…